PCRX News and Press, Pacira BioSciences Inc. From 11/01/23

2023-11-01 12:55:04 ET More on Pacira BioSciences Pacira BioSciences: Sell-Off On Pain Relief Specialist - But Recovery Not Guaranteed Pacira BioSciences: Economic Returns Languish Required Growth Rates Pacira BioSciences CEO David Stack to step down TD Cowen...

2023-10-30 17:17:47 ET Summary Pacira Biosciences' stock has reached its lowest value since the pandemic-induced market crash in March 2020, trading at just $27. The company's recent Q2 2023 earnings report showed a decline in EXPAREL revenues and downgraded FY23 guidance. Pac...

TAMPA, Fla., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its third quarter financial results before the open of the U.S. markets on Thursday November 2, 2023. Following the release, the company will host a live conference call and w...

SCHAUMBERG, Ill. and TAMPA, Fla., Oct. 12, 2023 (GLOBE NEWSWIRE) -- The American Society of Anesthesiologists (ASA) today announced Pacira BioSciences, Inc. (Nasdaq: PCRX) has joined ASA’s Industry Supporter Program to support the Society’s more than 56,000 physician anesthesiologis...

-- Enhances diversity and expertise in key areas including scientific, commercial, and financial -- TAMPA, Fla., Oct. 10, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, ...

2023-10-03 17:46:09 ET More than 80 stocks were identified by Morgan Stanley as potentially having technical pressure due to tax loss selling. A Morgan Stanley U.S. Equity Strategy report, published on Monday, showed 81 stocks that could have performance pressures due to market selling ...

SCHAUMBURG, Ill. and TAMPA, Fla., Oct. 02, 2023 (GLOBE NEWSWIRE) -- The American Society of Anesthesiologists (ASA) and Pacira BioSciences, Inc. (Nasdaq: PCRX), today announced a new grant of $2.5 million, by Pacira to the ASA Charitable Foundation, to advance the medical specialty of anesthesiol...

David Stack to Retire as Chairman and CEO Once Successor is Appointed Board Has Initiated Search for Successor TAMPA, Fla., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerativ...

TAMPA, Fla., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced its participation in an analyst-led fireside chat at the H.C. Wainwright 25 th Annual Global Investment Conference.  The pre-recorded audio of the virtual event can be accessed...

2023-08-05 12:28:15 ET Summary Pacira BioSciences posted mixed Q2 FY'23 earnings, with $34mm in quarterly FCF on $42mm pre-tax earnings. The company's EXPAREL unit sales were down YoY due to pricing issues from the 340B drug pricing program. Capital deployment and business ret...